Trial intelligence / Profile preview

Atazanavir/Ritonavir HAART in Thai HIV-infected Children

NCT01656109Phase 2Completed

Sponsor
HIV-NAT
Start
Jul 2011
Primary completion
Feb 2013
Modality
Small Molecules
Countries
1
01

Overview

A Phase 2 trial of atazanavir in human immunodeficiency virus infection (HIV), sponsored by HIV-NAT. Started Jul 2011; status: completed.

02

Drugs

atazanavir
03

Conditions

human immunodeficiency virus infection (HIV)

Beyond the preview

Go deeper on NCT01656109.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT01656109.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call